On April 26, 2021, Human N, Inc. (KOSDAQ:A032860) closed the transaction. The company has issued common shares for gross proceeds of KRW 9,999,999,090 in its second tranche bringing the total funds raised in the transaction to KRW 19,999,999,090.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,640 KRW | +1.11% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11Cr | |
-11.61% | 3.69TCr | |
+25.27% | 2.61TCr | |
-24.52% | 2.07TCr | |
+7.21% | 2.01TCr | |
+5.35% | 1.96TCr | |
-16.30% | 1.91TCr | |
+8.30% | 937.59Cr | |
-20.45% | 870.17Cr | |
-.--% | 778.83Cr |
- Stock Market
- Equities
- A032860 Stock
- News The Lamy Co., Ltd.
- Human N, Inc. announced that it has received KRW 19.99999909 billion in funding from Alpha Bio Labs Inc, Hansongneotech Co.,Ltd., NS Neotech Co., Ltd. and other investors